science-product-detail
https://doi.org/10.1093/humrep/deac103
Con: freeze-all for all? One size does not fit all
Lan N. Vuong 1,2
IVF has traditionally involved transfer of fresh embryos. However, a ‘freeze-all’ strategy where all embryos are cryopreserved for transfer in subsequent, unstimulated cycles has emerged as an alternative approach. This is thought to eliminate the negative effects of controlled ovarian stimulation on the endometrium and reduce the risk of ovarian hyperstimulation syndrome (OHSS). There are a growing number of studies evaluating live birth rates after use of a freeze-all versus fresh embryo transfer (ET) strategy. However, results to date are inconsistent. Certainly, the benefits of a freeze-all strategy appear to be less clear cut in ovulatory women with infertility, while those with a good ovarian response (more than 10 or 15 oocytes retrieved) may be suitable candidates. Variable responses to a freeze-all strategy compared with fresh ET have also been reported depending on whether cleavage stage embryos or blastocysts were transferred. In terms of safety, the risk of OHSS appears to be lower with a freeze-all strategy. For other safety endpoints, some appear to be better when a freeze-all approach is used (e.g. rates of pregnancy loss/miscarriage, preterm delivery, low birthweight and small for gestational age) while other complications are more common (e.g. hypertensive disorders of pregnancy/pre-eclampsia, large for gestational age and high birthweight). Preliminary longer-term data suggest that a freeze-all strategy does not have a negative impact on childhood development. Other factors to consider include time to pregnancy (longer after freeze-all) and the relative cost-effectiveness of the two approaches. Available data are too inconsistent to allow a freeze-all approach to be recommended for all patients. Instead, a personalized, balanced approach should be taken based on individual patient characteristics (especially steroid hormone levels on the day of trigger) and incorporating patient preference. While a freeze-all strategy might be the right choice for some patients, freeze-all is definitely not good for all.
KEYWORDS:
freeze-all / frozen embryo transfer / fresh embryo transfer / IVF / ICSI / live birth rate / ovarian hyperstimulation syndrome / cost-effectiveness
Download
Similar articles
- Review IVM for expected high responders: balancing the effectiveness and safety: In Reply [ H. N. A. Vu1, B.W. Mol2, L.N. Vuong1 ]
-
Review Endocrine requirements for oocyte maturation following hCG, GnRH agonist, and Kisspeptin during IVF treatment
[ Ali Abbara 1, Tia Hunjan 1, Vu N. A. Ho 2, Sophie A. Clarke 1, Alexander N. Comninos 1, Chioma Izzi-Engbeaya 1, Tuong M. Ho 2, Geoffrey H. Trew 3, Artsiom Hramyka 4, Tom Kelsey 4, Rehan Salim 3, Peter Humaidan 5, Lan N. Vuong 2,6 and Waljit S. Dhillo 1 ]
Objective: The maturation of oocytes to acq...
-
Review POSEIDON groups and their distinct reproductive outcomes: Effectiveness and cost-effectiveness insights from real-world data research
[ Sandro C.Estevesab, HakanYaralic, Lan N.Vuongdef, AlessandroConfortig, PeterHumaidanbh, CarloAlviggig ]
The Patient-Oriented Strategies Enc...
-
Review A cost-effectiveness analysis of freeze only or fresh embryo transfer in IVF of non-PCOS women
[ Le KD1, Vuong LN1,2, Ho TM1, Dang VQ1, Pham TD1, Pham CT3, Norman RJ4,5, Mol BWJ6. ]
STUDY QUESTION
Is a freeze-only strategy more cost-effective from a patient perspective than fresh embryo transfe... -
Review In-vitro maturation of oocytes versus conventional IVF in women with infertility and a high antral follicle count: a randomized non-inferiority controlled trial
[ Lan N. Vuong1,2, Vu N.A. Ho2, Tuong M. Ho2, Vinh Q. Dang2, Tuan H. Phung2, Nhu H. Giang2, Anh H. Le2, Toan D. Pham2, Rui Wang3, Johan Smitz4, Robert B. Gilchrist5, Robert J. Norman6,7, and Ben W. Mol3 ]
STUDY QUESTION